KELLY BILOF: Open Payments
NPI 1033428255 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 11 payments from 6 companies in 2025. Trend: 2023 $913 · 2024 $247 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $53 |
| ABBVIE INC. | 2 | $42 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $35 |
| Exact Sciences Corporation | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: MYFEMBREE, VRAYLAR, The Cologuard Plus Collection Kit, Veozah, UBRELVY, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
